News Brexit could deny children access to cancer drug trials Experts call for shake-up of EU regulation.
News US drug revenues far exceed R&D spend - report Analysis questions industry's rationale for high US prices.
News Pfizer and Merck's diabetes contender looks to challenge Jar... Merck and Pfizer have Boehringer and Lilly in their sights with ertugliflozin
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Pfizer's fast-tracked leukaemia candidate could rival CAR-Ts Antibody-drug conjugate with FDA gets six-month review.
News Is BMS the next pharma takeover target? Speculation mounting that Pfizer and others could try for $90 bn plus merger
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.